Our platform technology allows human liver cells to be created in quantity and quality that has never been achievable before.
Americans suffer from liver disease
U.S. adults died from liver disease in 2020*
*SOURCE: AMERICAN LIVER FOUNDATION
U.S. Market revenue opportunity (Cell transplantation, liver assist device, research)
Our bio-incubator expands cells up to 1000x
Pure primary hepatocytes, ready to use
Platform technology enables consistent product
The only platform that can scale up to meet demand
Bio-Incubator
Liver Assist Device
Allogeneic Hepatocytes (Patent-pending)